Drs. Stephen Rennard and Shawn Aaron discuss a manuscript from Dr. Rennard and his colleagues about using the CXCR2 antagonist MK-7123 to improve lung function in COPD. The podcast is moderated by AJRCCM podcast editor, Nitin Seam.
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"Out of the Blue: An AJRCCM Podcast","authorlink":""},"src":"https:\/\/media.transistor.fm\/6149b4fe\/0177cca1.mp3","thumb":{"src":"https:\/\/lystnimg.b-cdn.net\/podcastsnw-202206\/7715ec-b668-4a76-185e00_800.jpg"},"title":"Phase 2 Trial of a Novel COPD Treatment","link":"javascript:;","id":"item-8851822"}]
